Dataset Information


Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer.

ABSTRACT: BACKGROUND: The metastatic propensity of invasive ductal carcinoma (IDC) of the breast correlates with axillary node involvement and with expression of the proliferation antigen Ki-67, whereas ductal carcinoma in situ (DCIS) is non-metastasising. To clarify whether concomitant DCIS affects IDC prognosis, we compared Ki-67 expression and node status of size-matched IDC subgroups either with DCIS (IDC-DCIS) or without DCIS (pure IDC). METHODS: We analysed data from 1355 breast cancer patients. End points were defined by the association of IDC (with or without DCIS) with grade, nodal status, Ki-67, and ER/HER2. RESULTS: Size-matched IDC-DCIS was more likely than pure IDC to be screen detected (P=0.03), to occur in pre-menopausal women (P=0.002), and to be either ER-positive (P=0.002) or HER2-positive (P<0.0005), but less likely to be treated with breast-conserving surgery (P=0.004). Grade and Ki-67 were lower in IDC-DCIS than in pure IDC (P=0.02), and declined as the DCIS enlarged (P<0.01). Node involvement and lymphovascular invasion in IDC-DCIS increased with the size ratio of IDC to DCIS (P<0.01). A 60-month cancer-specific survival favoured IDC-DCIS over size-matched pure IDC (97.4 vs 96.0%). CONCLUSION: IDC co-existing with DCIS is characterised by lower proliferation and metastatic potential than size-matched pure IDC, especially if the ratio of DCIS to IDC size is high. We submit that IDC-DCIS is biologically distinct from pure IDC, and propose an incremental molecular pathogenesis of IDC-DCIS evolution involving an intermediate DCIS precursor that remains dependent for replication on upstream mitogens.


PROVIDER: S-EPMC2865763 | BioStudies | 2010-01-01

SECONDARY ACCESSION(S): 10.1038/sj.bjc.6605655

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6616329 | BioStudies
2014-01-01 | S-EPMC4076240 | BioStudies
2018-01-01 | S-EPMC6958306 | BioStudies
1000-01-01 | S-EPMC4480702 | BioStudies
2016-01-01 | S-EPMC4724280 | BioStudies
2018-01-01 | S-EPMC5955110 | BioStudies
1000-01-01 | S-EPMC3341870 | BioStudies
2022-08-02 | GSE195861 | GEO
2020-01-01 | S-EPMC7424652 | BioStudies
1000-01-01 | S-EPMC6221707 | BioStudies